Grey Wolf Health Corp. (TSXV:WOLF)

Market Cap	54.84M +52.8%
Revenue (ttm)	36.60M +27.5%
Net Income	1.77M +192.9%
EPS	0.05 +211.9%
Shares Out	34.49M
PE Ratio	30.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,823
Open	1.630
Previous Close	1.700
Day's Range	1.590 - 1.630
52-Week Range	1.000 - 1.850
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Grey Wolf Health

Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDA...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2025, Grey Wolf Health's revenue was 35.76 million, an increase of 33.30% compared to the previous year's 26.83 million. Earnings were 1.66 million, an increase of 135.11%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 28, 2026

Data Sources Report a data error